• SENSEX
    NIFTY 50
Business

Gilead's COVID-19 antiviral remdesivir gets conditional EU clearance

Updated : July 04, 2020 04:08 PM IST

The move comes just a week after the European Medicines Agency (EMA) gave its go-ahead for the drug produced by Gilead Sciences to be used in adults and adolescents from 12 years of age who are also suffering from pneumonia and require oxygen support.
Gilead's COVID-19 antiviral remdesivir gets conditional EU clearance

You May Also Like

Live TV

recommended for you

Advertisement